(Q46178855)

English

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Alejandro Forner

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

Josep M. Llovet

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

4

object named as

Jordi Rimola

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

Amelia J Hessheimer

5

object named as

Amelia J Hessheimer

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

Carlos Rodriguez-Lope

6

object named as

Carlos Rodriguez de Lope

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

7

object named as

María Reig

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

author name string

Carmen Ayuso

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

María Varela

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

Luís Bianchi

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

115

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

616-623

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

21 January 2018

Historical and methodological developments in clinical trials at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

RECIST revisited: a review of validation studies on tumour assessment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer clinical trial end points: "RECIST"ing a step backwards.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

CT, RECIST, and malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of clinical outcome in treated neuroendocrine tumours of carcinoid type using functional volumes on 111In-pentetreotide SPECT imaging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring response in a post-RECIST world: from black and white to shades of grey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Update in methodology and conduct of cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug development in oncology: classical cytotoxics and molecularly targeted agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24050

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24050

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117042

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46178855&oldid=1755105898"